LFMD Q3 2025 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q3 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$60M+13.0% YoY

Gross Profit

$53M87.7% margin

Operating Income

-$2M-3.3% margin

Net Income

-$4M-6.3% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

-3.3%

Cash Flow

Operating Cash Flow

-$147,136

Free Cash Flow

$6M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$66M

Total Liabilities

$63M

Stockholders' Equity

$1M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$60M	$53M	+13.0%
Gross Profit	$53M	$48M	+9.3%
Operating Income	-$2M	-$4M	+50.7%
Net Income	-$4M	-$5M	+18.3%

Revenue Segments

Product and Services

$3M100%